Friday, March 29, 2019
The purpose of this transmittal is to introduce Policy Number: HCDMA-19-001 which removes the Prior Authorization requirements for Buprenorphine containing drug products and Vivitrol.
The purpose of this transmittal is to introduce Policy Number: HCDMA-19-001 which removes the Prior Authorization requirements for Buprenorphine containing drug products and Vivitrol.
